tradingkey.logo
搜索

Bionano Genomics Inc

BNGO
添加自选
1.150USD
-0.040-3.36%
收盘 05/15, 16:00美东报价延迟15分钟
12.35M总市值
亏损市盈率 TTM

Bionano Genomics Inc

1.150
-0.040-3.36%

关于 Bionano Genomics Inc 公司

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Bionano Genomics Inc简介

公司代码BNGO
公司名称Bionano Genomics Inc
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)
员工数量98
证券类型Ordinary Share
年结日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编92121
电话18588887600
网址https://bionano.com/
公司代码BNGO
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)

Bionano Genomics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
362.00
-5.52%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
261.00
-1.15%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.92%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-535.29%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Kristiina Vuori, M.D., Ph.D.
Dr. Kristiina Vuori, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alka Chaubey, Ph.D.
Dr. Alka Chaubey, Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
362.00
-5.52%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
261.00
-1.15%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.92%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-535.29%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Consumables
13.97M
49.00%
Software
6.41M
22.48%
Instruments
6.36M
22.32%
Services and other
1.76M
6.19%
地区USD
名称
营收
占比
EMEIA
14.11M
49.49%
Americas
12.18M
42.72%
Asia Pacific
2.22M
7.79%
业务
地区
业务USD
名称
营收
占比
Consumables
13.97M
49.00%
Software
6.41M
22.48%
Instruments
6.36M
22.32%
Services and other
1.76M
6.19%

股东统计

更新时间: 5月14日 周四
更新时间: 5月14日 周四
持股股东
股东类型
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
4.73%
GSA Capital Partners LLP
3.19%
Abbe (Richard)
2.91%
Iroquois Capital Management, LLC
1.75%
DRW Securities, LLC
1.52%
其他
85.90%
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
4.73%
GSA Capital Partners LLP
3.19%
Abbe (Richard)
2.91%
Iroquois Capital Management, LLC
1.75%
DRW Securities, LLC
1.52%
其他
85.90%
股东类型
持股股东
占比
Hedge Fund
5.76%
Corporation
4.73%
Investment Advisor
4.02%
Individual Investor
2.92%
Investment Advisor/Hedge Fund
0.79%
Research Firm
0.29%
其他
81.48%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
109
1.17M
10.52%
+32.26K
2025Q4
123
914.11K
2.31%
--
2025Q3
133
914.11K
2.58%
+813.59K
2025Q2
185
100.52K
13.17%
-3.70K
2025Q1
250
104.22K
14.32%
-326.48K
2024Q4
274
101.50K
13.43%
+9.88K
2024Q3
289
91.66K
15.30%
-74.07K
2024Q2
302
110.36K
23.52%
-110.43K
2024Q1
309
82.51K
16.21%
-65.29K
2023Q4
315
103.94K
16.84%
+13.56K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Lincoln Alternative Strategies LLC
525.00K
4.73%
+525.00K
--
Sep 17, 2025
GSA Capital Partners LLP
337.78K
3.05%
+337.78K
--
Dec 31, 2025
Abbe (Richard)
322.53K
2.91%
+322.53K
--
Sep 30, 2025
Iroquois Capital Management, LLC
194.66K
1.75%
+194.66K
--
Sep 30, 2025
DRW Securities, LLC
168.45K
1.52%
+168.45K
--
Dec 31, 2025
Abante Asesores Gestión, S.G.I.I.C., S.A.
95.70K
0.86%
+95.70K
--
Dec 31, 2025
Geode Capital Management, L.L.C.
66.77K
0.6%
+39.93K
+148.77%
Dec 31, 2025
Carret Asset Management, LLC
44.10K
0.4%
+19.10K
+76.40%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
公告日期
除权除息日
类型
比率
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI